Format

Send to

Choose Destination
Pain. 2017 Jan;158(1):180-182.

Clinical assessment of new antineuropathic strategies for chemotherapy-induced peripheral neuropathy: pain should not be the principal endpoint.

Author information

1
aUniversité Clermont Auvergne, Inserm, U1107, NEURO-DOL, CHU Clermont-Ferrand, délégation à la recherche clinique et à l'innovation, Clermont-Ferrand, France bCHU Clermont-Ferrand, délégation à la recherche clinique et à l'innovation, Clermont-Ferrand, France cUniversité Clermont Auvergne, Inserm, U1071, USC INRA 2018, M2iSH, CHU Clermont-Ferrand, service de chirurgie et oncologie digestive, Clermont-Ferrand, France.

Comment in

PMID:
27984530
DOI:
10.1097/j.pain.0000000000000743
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center